The Valley Desk

NCT04136171 · Interventional trial

CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Overall registry status Completed

Phase 3

Conditions Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov